The last year has seen milestones in the gene therapy field, with FDA approvals to treat cancer and an inherited blinding disorder. New findings from a team led by University of Pennsylvania vision ...
Dr. Park’s research focuses on the biology of photoreceptor cells and structure-function studies of rhodopsin and other G protein-coupled receptors (GPCRs) using cutting-edge biochemical, biophysical ...
(Philadelphia, PA) -- Retinitis pigmentosa (RP) is an inherited eye disease that causes visual disability leading to blindness. Over the last 15 years, researchers have pinpointed defects in dozens of ...
CAMBRIDGE, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced ex vivo and in vivo preclinical data for its experimental ...
Scientists believe they have discovered a special antibody which may lead to a treatment for Retinitis Pigmentosa, a condition that causes loss of central vision, as well as night and color vision. A ...
This image shows the structure of rhodopsin embedded in a membrane. The red structure in the middle is the retinal chromophore responsible for absorbing visible light. (Image credit: Kiser et al., ...
Constanze Bickelmann, James M. Morrow, Jing Du, Ryan K. Schott, Ilke van Hazel, Steve Lim, Johannes Müller, Belinda S. W. Chang Evolution, Vol. 69, No. 11 (NOVEMBER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback